Showing 6201-6210 of 9245 results for "".
How Viable is Pay-for-Performance in Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0509_03-php/22825/Though Pay-for-Performance has affected primary care medicine for years, it has only recently expanded into specialized medicine. Experts discuss its eventual impact on dermatology.Is Topical Therapy for Psoriasis Resurging?
https://practicaldermatology.com/topics/psoriasis/PD0409_03-php/22841/While biologics have changed the way patients and physicians think about psoriasis, topical therapy remains important for a majority of patients.You Want to Start A New Practice: Now What?
https://practicaldermatology.com/topics/general-topics/PD0309_12-php/22866/After making the decision to start a practice, constructing a solid business plan and financial overview is critical.Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Selecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.Is Irritable Bowel Linked to Irritable Skin?
https://practicaldermatology.com/columns/clinical-focus-1/is-irritable-bowel-linked-to-irritable-skin/23324/Exploring irritable bowel syndrome’s link to dermatologic conditions.A Brief Compendium of Some Long-Forgotten Remedies for Dermatology
https://practicaldermatology.com/topics/general-topics/a-brief-compendium-of-some-long-forgotten-remedies-for-dermatology/20313/Is it time to drop the one-size-fits-all approach and consider remedies of the past?Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Post-Inflammatory Hyperpigmentation in Skin of Color: An Updated Review
https://practicaldermatology.com/topics/pigmentary-disorders/post-inflammatory-hyperpigmentation-in-skin-of-color-an-updated-review/67255/Treatments for PIH involve topical agents, oral agents, and procedures, the selection of which is determined on both depth of PIH and anatomic location.Take 5: Promising Therapies for Rosacea
https://practicaldermatology.com/columns/take-5/take-5-promising-therapies-for-rosacea/21716/Five new studies offer insights for treating and understanding rosacea.